Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

p-Benzoquinone dioxime: Target Organs and Levels of Evidence for TR-179

Bioassay of p-Quinone Dioxime for Possible Carcinogenicity (CASRN 105-11-3)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
p-Benzoquinone dioxime 105-11-3	10/25/1978	Dosed-Feed R: 0,375,750, M: 0,750,1500 PPM/50 PER GROUP	Litton Bionetics, Inc.

Levels of Evidence

Male Rats: Negative

Female Rats: Positive

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Urinary Bladder: (TRANSITIONAL CELL PAPILLOMA OR CARCINOMA OR SQUAMOUS CELL CARCINOMA)

p-Benzoquinone dioxime: Target Organs and Levels of Evidence for TR-179

Bioassay of p-Quinone Dioxime for Possible Carcinogenicity (CASRN 105-11-3)

Levels of Evidence

Male Rats: Negative

Female Rats: Positive

Male Mice: Negative

Female Mice: Negative